Nicholas Lopardo - PerkinElmer Lead Independent Director
| PKIDelisted Stock | USD 115.24 0.74 0.64% |
Director
Mr. Nicholas A. Lopardo is an Independent Director of Perkinelmer Inc. Mr. Lopardo was Chairman and Chief Executive Officer of NAL Group, an investment holding company formerly known as Susquehanna Capital Management Group, since January 2002. Mr. Lopardo retired in December 2001 as Vice Chairman of State Street Bank and Trust Company and Chairman and Chief Executive Officer of State Street Global Advisors, the banks investment management group. Mr. Lopardo had been associated with State Street Bank and Trust Company since 1987, and previously held several executive level positions including Executive Vice President. Mr. Lopardo has almost forty years of experience in the pension industry, having served in a variety of roles with Equitable Life Assurance Society related to pension marketing, client relationships, and pension investment advisory services. Mr. Lopardo also serves as a director of several privately held companies. He served eight years as a member of the board of directors of Susquehanna University, holding the position of Chairman of that board in 2000 and 2001. He was also Chairman of the advisory board of the Weiss School of Business at Susquehanna University, and is Chairman Emeritus of the board and a lifetime trustee of the Landmark School, a premier secondary school for students with languagebased learning disabilities. Mr. Lopardo is also a board member of Boston Partners in Education and USA Hockey Foundation since 1996.
| Age | 70 |
| Tenure | 28 years |
| Phone | 781 663 6900 |
| Web | https://www.perkinelmer.com |
PerkinElmer Management Efficiency
The company has Return on Asset of 0.0369 % which means that on every $100 spent on assets, it made $0.0369 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0706 %, implying that it generated $0.0706 on every 100 dollars invested. PerkinElmer's management efficiency ratios could be used to measure how well PerkinElmer manages its routine affairs as well as how well it operates its assets and liabilities.The company has 3.92 B in debt with debt to equity (D/E) ratio of 0.65, which is OK given its current industry classification. PerkinElmer has a current ratio of 1.98, which is typical for the industry and considered as normal. Debt can assist PerkinElmer until it has trouble settling it off, either with new capital or with free cash flow. So, PerkinElmer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PerkinElmer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PerkinElmer to invest in growth at high rates of return. When we think about PerkinElmer's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| John Connaughton | IQVIA Holdings | 54 | |
| Robert Williams | Laboratory of | 72 | |
| Declan McKeon | ICON PLC | 63 | |
| Roy Whitfield | Illumina | 63 | |
| Robert Bertolini | Charles River Laboratories | 59 | |
| JeanLuc Belingard | Laboratory of | 72 | |
| Jeffrey Davis | Laboratory of | 57 | |
| George Milne | Charles River Laboratories | 77 | |
| William End | IDEXX Laboratories | 68 | |
| Paul Clark | Agilent Technologies | 72 | |
| Nelson Chai | Thermo Fisher Scientific | 55 | |
| Virginia Wilson | Charles River Laboratories | 66 | |
| James Mullen | Thermo Fisher Scientific | 62 | |
| Thomas Salice | Waters | 61 | |
| Todd Sisitsky | IQVIA Holdings | 49 | |
| Joan Garahy | ICON PLC | 54 | |
| Stuart Essig | IDEXX Laboratories | 56 | |
| John Thompson | Illumina | 68 | |
| Sanders Williams | Laboratory of | 69 | |
| Jeffrey Huber | Illumina | 46 | |
| Colleen Goggins | IQVIA Holdings | 66 | |
Management Performance
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 |
PerkinElmer Leadership Team
Elected by the shareholders, the PerkinElmer's board of directors comprises two types of representatives: PerkinElmer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PerkinElmer. The board's role is to monitor PerkinElmer's management team and ensure that shareholders' interests are well served. PerkinElmer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PerkinElmer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michel Vounatsos, Independent Director | ||
| Sylvie Gregoire, Independent Director | ||
| Pascale Witz, Independent Director | ||
| Miriame Victor, Chief Commercial Officer, Senior Vice President | ||
| Jonathan DiVincenzo, Sr. VP and President of Environmental Health | ||
| Patrick Sullivan, Independent Director | ||
| Stephen Willoughby, VP ESG | ||
| Tajinder Vohra, Senior Vice President Global Operations | ||
| Prahlad Singh, Senior Vice President and President - Diagnostics | ||
| Robert Friel, Chairman, CEO and President and Member of Fin. Committee | ||
| Vicki Sato, Independent Director | ||
| Maxwell Krakowiak, VP CFO | ||
| Daniel Tereau, Senior Vice President Strategy and Business Development | ||
| Alexandros Michas, Independent Non-Executive Chairman of the Board | ||
| Nicholas Lopardo, Lead Independent Director | ||
| Franklin Witney, Director | ||
| Joel Goldberg, Senior Vice President - Administration, General Counsel, Secretary | ||
| James Corbett, Sr. VP and President of Human Health | ||
| Kenton Sicchitano, Independent Director | ||
| Samuel Chapin, Independent Director | ||
| James Mock, Chief Financial Officer, Senior Vice President | ||
| Andrew Okun, Chief Accounting Officer, Vice President, Treasurer | ||
| Peter Barrett, Independent Director | ||
| Deborah Butters, Chief Human Resource Officer, Senior Vice President | ||
| Frank Witney, Independent Director | ||
| John Letcher, Senior Vice President - Human Resources | ||
| Alexis Michas, Independent Non-Executive Chairman of the Board | ||
| Jon DiVincenzo, Senior Vice President and Presidentident - Environmental Health | ||
| Masoud Toloue, VP Diagnostics | ||
| Frank Wilson, CFO and Sr. VP |
PerkinElmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PerkinElmer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 22.3 B | |||
| Shares Outstanding | 126.41 M | |||
| Shares Owned By Insiders | 0.26 % | |||
| Shares Owned By Institutions | 86.25 % | |||
| Number Of Shares Shorted | 3.53 M | |||
| Price To Earning | 21.07 X |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PerkinElmer using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in PerkinElmer Stock
If you are still planning to invest in PerkinElmer check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PerkinElmer's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |